Pulse actinomycin D as first-line treatment of low-risk post-molar non-choriocarcinoma gestational trophoblastic neoplasia

BACKGROUND: Little data exists predicting the resistance to actinomycin D (Act-D) single-agent for gestational trophoblastic neoplasia (GTN). The objective was to determine the overall success of pulse Act-D and the factors predictive of resistance to pulse Act-D in the treatment of low-risk, non-ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Lei, Wan, Xirun, Feng, Fengzhi, Ren, Tong, Yang, Junjun, Zhao, Jun, Jiang, Fang, Xiang, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5966914/
https://www.ncbi.nlm.nih.gov/pubmed/29792175
http://dx.doi.org/10.1186/s12885-018-4512-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5966914/
https://www.ncbi.nlm.nih.gov/pubmed/29792175
http://dx.doi.org/10.1186/s12885-018-4512-5

Ejemplares similares